University of Iowa spinoff company Viewpoint Molecular Targeting has been recognized as among the “Best University Startups 2016” in the U.S. and has received an invitation to present at the National Council of Entrepreneurial Tech Transfer (NCET2) University Startups Demo Day on Sept. 20 in Washington, D.C.
Founded by College of Medicine faculty Michael K. Schultz, PhD, radiology, and Frances L. Johnson, MD, internal medicine, Viewpoint was one of 35 university startup companies (of ~800) from around the country to be selected. “Viewpoint clearly stands out as having an exceptional blend of innovative biomedical technology and business leadership that will take the company to the next level” says NCET2 Associate Director Ria Ancheta-Adrias. “The team was an obvious choice for a Best University Startup 2016 designation.”
The recognition secures an opportunity at Demo Day for the company to present to corporations, venture capitalists, angel investors and members of Congress. “We’re excited about the progress the company is making and honored to be in the midst of some outstanding technologies and business development teams.” Says Viewpoint Founder and Chief Science Officer Michael Schultz, PhD.